Cargando…
T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
T-cells have a natural ability to fight cancer cells in the tumour microenvironment. Due to thymic selection and tissue-driven immunomodulation, these cancer-fighting T-cells are generally low in number and exhausted. One way to overcome these issues is to genetically alter T-cells to improve their...
Autores principales: | Crowther, Michael D., Svane, Inge Marie, Met, Özcan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407663/ https://www.ncbi.nlm.nih.gov/pubmed/32630096 http://dx.doi.org/10.3390/cells9071588 |
Ejemplares similares
-
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
por: Lorentzen, Cathrine Lund, et al.
Publicado: (2022) -
Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2020) -
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
por: Chamberlain, Christopher Aled, et al.
Publicado: (2022) -
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022) -
CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead
por: Zhang, Qingyang, et al.
Publicado: (2020)